How the world’s biggest pharma and biotech companies paid their typical worker in 2023

Based on the search results, here are some key points about how major pharmaceutical and biotech companies paid their typical workers in 2023:

Gilead Sciences had the highest median employee pay at $205,86617.

2. Other top-paying companies included:

* - Amgen:*
$166,322 median pay17

* - Regeneron Pharmaceuticals:*
$165,843 median pay17

* - Eli Lilly:*
$157,937 median pay2

Johnson & Johnson, one of the largest pharma companies, had a median employee pay of $84,0002.
Pfizer's median employee pay was $74,008, which was among the lower figures for major pharma companies2 6.
AbbVie reported a median employee pay of $151,9912.
Overall, the typical biopharma worker made $199,048 in 2023, according to an analysis by Endpoints News6.

7. There were significant pay gaps between CEOs and median workers at many companies. For example:

* - Johnson & Johnson had a 338:*
1 CEO-to-median employee pay ratio2

* - Pfizer had a 291:*
1 ratio2

* - AbbVie had a 169:*
1 ratio2

Salaries tended to be highest for director and senior management roles, with director-level positions having a median maximum salary of $230,75019.
Research scientist and specialist roles had lower but still substantial salaries, with a median maximum of $120,00019.
Location played a role in compensation, with companies in biotech hubs like San Francisco, San Diego and Boston tending to offer higher median wages3.

Overall, the data shows considerable variation in median pay across major pharma and biotech companies, with some offering very high compensation to typical workers while others had more modest median salaries. There were also large disparities between executive and median worker pay at many firms.